Esketamine, new depression drug from Johnson & Johnson, approved by FDA – Business Insider


Called Spravato or esketamine and developed by Johnson & Johnson, the drug is a nasal spray designed to treat severe forms of depression that don’t respond to other medications. via Pocket
from bitly https://read.bi/2EzD98E
via IFTTT

Advertisements